Adamas Pharmaceuticals Inc

ADMS 
(NASDAQ) 
 
$ 29.23 <%= Resources.Global.txtDown %>
Updated 20:49:09
Change % -1.71% Stock price decreasing
Change -0.51 Stock price decreasing
Volume 93,694
High $ 30.10
Low $ 29.16
Open $ 29.39
ISIN
Prev close $ 29.74
# of shares 26.98M
Market cap 788.69M USD
Intraday

Market closed
Adamas Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  29.23 -10.5% Stock price decreasing 3.7% Stock price increasing 12.3% Stock price increasing -13.2% Stock price decreasing 82.6% Stock price increasing
Powered by TradingView

News about Adamas Pharmaceuticals Inc

  • English
  • Regulatory news

Company profile

Adamas Pharmaceuticals Inc is primarily focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company has an approved product called GOCOVRI for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia. The company's portfolio also includes two drugs commercially available in the United States for indications relating to Alzheimer's disease: Namzaric capsules and Namenda XR extended release capsules.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 May 2018 23:47:03
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB5 - 2018-05-24 00:47:03 - 2018-05-23 23:47:03 - 1000 - Website: OKAY